SHPP.694442 15560863 31102023

Laboratory Investigation Report
Patient Name : Mr. Roop Singh 20424552 Centre : 794 - Max Hospital - Vaishali
Age/Gender : 32 Y 0 M 30 D /M OP/IP No/UHID : OP/VACR798905/
MaxID/Lab ID : SHPP.694442/0369102343827 Collection Date/Time : 31/Oct/2023 05:30PM
Ref Doctor : SELF Reporting Date/Time : 31/Oct/2023 07:16PM
Clinical Biochemistry
SIN No:VSH1997271
HbA1c (Glycated/ Glycosylated Hemoglobin) Test*
HPLC
Date 31/Oct/2023 Unit Bio Ref

05:30PM Interval
Glycosylated 5.4 % 4.27 - 6.07
Haemoglobin(Hb A1c)
Glycosylated 35.51 mmol/mol < 39.0
Haemoglobin(Hb A1c) IFCC
Average Glucose Value For 108.28 mg/dL
the Last 3 Months
Average Glucose Value For 6.00 mmol/L
the Last 3 Months IFCC
Interpretation The following HbA1c ranges recommended by the American Diabetes Assocation(ADA) may be used as an aid in the diagnosis of diabetes
mellitus.
HbA1C(NGSP %) HbA1C(IFCC mmol/mol) Suggested Diagnosis

> 6.5 > 48 Diabetic
5.7 - 6.4 39 - 47 Pre- Diabetic
< 5.7 < 39 Non - Diabetic
HbA1C provides a useful index of average glycaemia over the preceding 6-8 weeks.
It is suggested that HbA1c is measured every 6 months in stable patients, every 3 months in patients with unstable metabolic control and every month in pregnancy.
Increased Glycated hemoglobin is a reflection of Hyperglycemia.
Kindly correlate with clinical findings
*** End Of Report ***
Page 1 of 12
Test Performed at :794 - Max Hospital - Vaishali, W-3, Sector-1, Vaishali, Ghaziabad-201012, U.P
Booking Centre :794 - Max Hospital - Vaishali, W-3, Sector-1, Vaishali, Ghaziabad-201012, U.P, 0120418800
The authenticity of the report can be verified by scanning the Q R Code on top of the page
Hematology
SIN No:VSH1997271
Test Name Result Unit Bio Ref Interval
ESR ,EDTA*
Modified (Westergren)
ESR (Modified Westergren) 06 mm/hr <=10

Modified (Westergren)
Interpretation
(Syn: Erythrocyte Sedimentation Rate)

ESR is measured as red cells fall through a column of blood. It is a sensitive index of plasma protein change. It can be affected by age, sex, menstrual cycle, pregnancy
and drugs( e.g. OCP, steroids).
No fasting sample is required for ESR.
ESR is performed for the diagnostic purpose for temporal arteritis and polymyalgia rhematica. It is also used for chronic inflammation.
High ESR is seen in - inflammatory disorders ( e.g. infection , rheumatoid disease, tuberculosis), presence of paraproteinemia ( e.g. multiple myeloma, lymphoma)
and anaemia.
Low ESR is seen in - polycythemia, hypofibrinogemia, poikilocytosis, spherocytosis and sickle cell anaemia.
Normal ESR does not exclude organic disease.
Page 2 of 12
SIN No:VSH1997271
Fasting Blood Sugar (Glucose) , (FBS), Fluoride Plasma
Date 31/Oct/2023 Unit Bio Ref Interval
05:30PM
Glucose (Fasting) 86 mg/dl 74 - 99
Hexokinase
Lipid Profile,Serum
05:30PM Interval
Cholesterol 203 mg/dl < 200
Enzymatic
HDL Cholesterol 47 mg/dl > 40
Homogeneous enzymatic
LDL Cholesterol 135 mg/dl < 100
Homogeneous enzymatic
Triglyceride 108.0 mg/dl < 150
Enzymatic
VLDL Cholesterol 21.6 mg/dl < 30
Calculated
Total Cholesterol/HDL Ratio 4.3 .. < 4.9
Calculated
Non-HDL Cholesterol 156.00 mg/dl < 130
Calculated
HDL/LDL 0.35 Ratio 0.3 - 0.4
Calculated
Interpretation
Optimal: < 100 mg/dL

Near Optimal/ Above Optimal: 100-
Desirable: < 200 mg/dL
129
Borderline High: 200-239
Total mg/dL
mg/dL LDL-C
Cholesterol Borderline High: 130-159 mg/dL
High ≥ 240 mg/dL
High: 160-189 mg/dL
Very High: ≥ 190 mg/dL
Normal: <150 mg/dL

Low HDL: < 40 mg/dL Borderline High: 150-199 mg/dL
HDL-C Triglyceride
High HDL: ≥ 60 mg/dL High: 200-499 mg/dL
Very High: ≥ 500 mg/dL
Page 3 of 12
SIN No:VSH1997271
Liver Function Test (LFT), Serum
05:30PM
Total Protein 7.00 g/dL 6.6-8.7
Biuret
Albumin 4.7 g/dl 3.5-5.2
BCG
Globulin 2.3 g/dl 1.8-3.6
Calculated
A.G. ratio 2.0 1.2 - 1.5
Calculated
Bilirubin (Total) 0.7 mg/dl 0.2-1.2
Diazo
Bilirubin (Direct) 0.4 mg/dl 0-0.3
Diazo
Bilirubin (Indirect) 0.30 mg/dl 0.1 - 1.0
Calculated
SGOT- Aspartate 43.5 U/L 0-40
Transaminase (AST)
IFCC without pyridoxal phosphate
SGPT- Alanine 56.7 U/L 0-40
Transaminase (ALT)
IFCC without pyridoxal phosphate
AST/ALT Ratio 0.77 Ratio
Calculated
Alkaline Phosphatase 107 U/L 40 - 129
GGTP (Gamma GT), Serum 30.0 U/L 8-61
ENZYMATIC COLORIMETRIC
ASSAY
Interpretation AST/ALT Ratio : -

In Case of deranged AST and/or ALT, the AST/ALT ratio is > 2.0 in alcoholic liver damage and < 2.0 in non – alcoholic liver damage
Page 4 of 12
Hematology
SIN No:VSH1997271
CBC (Complete Blood Count), Whole Blood EDTA
05:30PM
Haemoglobin 14.4 g/dl 13.0 - 17.0
Modified cyanmethemoglobin
Packed Cell, Volume 44.4 % 40-50
Calculated
Total Leucocyte Count (TLC) 6.9 10~9/L 4.0-10.0
Electrical Impedance
RBC Count 4.65 10~12/L 4.5-5.5
MCV 95.5 fL 83-101
MCH 31.0 pg 27-32
Calculated
MCHC 32.5 g/dl 31.5-34.5
Calculated
Platelet Count 298 10~9/L 150-410
MPV 9.0 fl 7.8-11.2
Calculated
RDW 14.9 % 11.5-14.5
Calculated
Differential Cell Count

VCS / Light Microscopy
Neutrophils 58.3 % 40-80

Lymphocytes 30.1 % 20-40
Monocytes 7.4 % 2-10
Eosinophils 3.8 % 1-6
Basophils 0.4 % 0-2
Absolute Leukocyte Count

Calculated from TLC & DLC
Absolute Neutrophil Count 4.02 10~9/L 2.0-7.0

Absolute Lymphocyte Count 2.1 10~9/L 1.0-3.0
Absolute Monocyte Count 0.51 10~9/L 0.2-1.0
Absolute Eosinophil Count 0.26 10~9/L 0.02-0.5
Absolute Basophil Count 0.03 10~9/L 0.02-0.1

Page 5 of 12
Hematology
SIN No:VSH1997271
Page 6 of 12
Serology
SIN No:VSH1997271
Test Name Result Unit Bio Ref Interval
VDRL/RPR, Serum
RPR(Syphilis) Non Reactive
Slide Flocculation
Comment
Interpretation
1. It is a screening test for syphilis which is useful for following the progression of disease and response to therapy. Rising titers are of immense value in
confirming the diagnosis.
2. Biological false positive reactions exhibit low titers and are seen in conditions like Viral fevers, Mycoplasma infection, Chlamydia infection, Malaria,
Immunizations, Pregnancy, Autoimmune disorders & past history of Treponemal infection.
3. It is advisable to confirm the diagnosis by tests such as TPHA & FTA-ABS.
4. A definitive clinical diagnosis should not be made by result of a single test only, but should be made by taking clinical history and other laboratory findings
in to account.
Page 7 of 12
SIN No:VSH1997271
Renal Profile,Serum + Urine
Urea, Serum
05:30PM
Urea 18.0 mg/dl 5-50
Urease GLDH
B.U.N (Blood Urea Nitrogen), Serum

05:30PM
Blood Urea Nitrogen 8.33 mg/dl 6-20
Urease GLDH
Comment Serum urea nitrogen is increased in Intra vascular volume depletion, diuretics, CCF, GI bleeding, tetracycline intake and renal failure.
Reduced levels are seen in chronic liver disease and alcohol abuse.
Page 8 of 12
SIN No:VSH1997271
Creatinine, Serum
05:30PM Interval
Creatinine 0.7 mg/dL 0.7-1.2
Jaffe Kinetic
eGFR by MDRD 130.62 ml/min/1.73
MDRD m²
eGFR by CKD EPI 2021 124.60
Ref. Range
eGFR - Estimated Glomerular Filteration Rate is calculated by MDRD equation which is most accurate for GFRs ≤ 60ml / min
/1.73 m².MDRD equation is used for adult population only.
Category Ref Interval (ml / min / 1.73 m² ) Condition
Normal or High
G1 ≥90
G2 60 - 89 Mildly Decreased
G3a 45 - 59 Mildly to Moderately Decreased
G3b 30 - 44 Moderately to Severly Decreased
G4 15 - 29 Severly Decreased
G5 < 15 Kidney failure
Sodium, Serum
05:30PM
Sodium 140.0 mmol/l 135-148
ISE Indirect
Page 9 of 12
SIN No:VSH1997271
Potassium, Serum
05:30PM
Potassium 3.6 mmol/l 3.5 - 5.3
ISE Indirect
Chloride, Serum
05:30PM
Chloride 100 mmol/l 101-111
ISE Indirect
Page 10 of 12
SIN No:VSH1997271
Bicarbonate, Serum*
05:30PM
Bicarbonate 24.4 mmol/l 22-32
PEPC
Page 11 of 12
SIN No:VSH1997271
Calcium, Serum
05:30PM
Calcium (Total) 8.9 mg/dl 8.6-10.2
O-CPC
Comment
Increased in Primary and Tertiary hyperparathyroidism, malignant disease with bone involvement, Polycythemia vera, pheochromocytoma and Sarcoidosis.
Advise: PTH testing. If normal or increased, then check urine Ca++/ Creatinine ratio to exclude Familial benign hypocalciuric hypercalcemia (FBHH)
Decreased in surgical or congenital hyperparathyroidism; Vitamin D deficiency, chronic renal failure; magnesium deficiency, prolonged anticonvulsant therapy, acute
pancreatitis, hyperphosphatemia, massive blood transfusion, leprosy, proximal and distal renal tubular disease, alcoholism and hepatic cirrhosis.
Advice: Albumin, Phosphate, Creatinine, Alkaline Phosphatase and PTH.

Results to follow:
Blood Grouping and RH Factor : 01/Nov/2023 07:00 PM,Urine Routine And Microscopy : 01/Nov/2023 07:00 PM
Page 12 of 12

SHPP.694442 15560863 31102023

Uploaded by

Copyright:

Available Formats

SHPP.694442 15560863 31102023

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

SHPP.694442 15560863 31102023

Uploaded by

Copyright:

Available Formats

Laboratory Investigation Report

Date 31/Oct/2023 Unit Bio Ref

HbA1C(NGSP %) HbA1C(IFCC mmol/mol) Suggested Diagnosis

Kindly correlate with clinical findings

*** End Of Report ***

ESR (Modified Westergren) 06 mm/hr <=10

(Syn: Erythrocyte Sedimentation Rate)

Kindly correlate with clinical findings

*** End Of Report ***

Optimal: < 100 mg/dL

Normal: <150 mg/dL

Interpretation AST/ALT Ratio : -

Kindly correlate with clinical findings

*** End Of Report ***

Differential Cell Count

Neutrophils 58.3 % 40-80

Absolute Leukocyte Count

Absolute Neutrophil Count 4.02 10~9/L 2.0-7.0

Kindly correlate with clinical findings

*** End Of Report ***

Kindly correlate with clinical findings

*** End Of Report ***

B.U.N (Blood Urea Nitrogen), Serum

Category Ref Interval (ml / min / 1.73 m² ) Condition

Kindly correlate with clinical findings

You might also like

* End Of Report *

* End Of Report *

* End Of Report *

* End Of Report *

* End Of Report *